10.21147/j.issn.1000-9604.2022.06.13
Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
Pancreatic cancer is a serious threat to human health, and the incidence is on the rise. Due to lack of obvious symptoms in early stage, it is often diagnosed in late stage. Its biological behavior is poor, and up to now, surgery and medical treatment have not achieved optimal effect, many efforts have been made to improve the diagnosis and treatment of pancreatic cancer. In 2022, the National Guidelines of Diagnosis and Treatment of pancreatic cancer 2022 in China (English version) (1) was updated and released by the National Health Commission of the People's Republic of China based on the 2018 edition. Some updated points will be discussed.
national、english、cancer、china、comments、diagnosis、guidelines、pancreatic、treatment、version
34
S;H313;G2
2023-04-21(万方平台首次上网日期,不代表论文的发表时间)
共7页
637-643